Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Inverness new rapid test for C Diff associated disease

Inverness Medical Innovations : 24 September, 2008  (New Product)
Inverness Medical has launched the new Techlab C Diff Quik Chek Complete rapid test as an in vitro diagnostic aid for Clostridium difficile associated disease (CDAD).
C difficile is responsible for the most common form of hospital-acquired diarrhoea and antibiotic associated colitis. Although primarily a hospital acquired disease, C difficile infection is increasingly occurring in community outpatient settings. This is causing a major problem for hospital and community care settings because the number of patients at risk of C difficile infection is substantial. Highly infectious and dangerous in the immunocompromised or elderly patients, C difficile infection can be life threatening.

Techlab C Diff Quik Chek Complete test detects glutamate dehydrogenase (GDH) and C difficile toxins A and B in one simple assay, and can be used for screening while confirming the presence of toxigenic C difficile strains. C difficile antigen glutamate dehydrogenase (GDH) is common to all strains of C difficile and has been identified as a screening marker for the infection.

The test provides results in less than 30 minutes from faecal samples, enabling rapid diagnosis and initiation of appropriate patient management. Patients can be effectively isolated at an earlier stage, reducing the risk of cross contamination and widespread outbreaks. In addition, the new Techlab C Diff Quik Chek Complete test detects toxigenic and non-toxigenic strains, including the new hyper-virulent C difficile strain BI/NAP1/027 which is causing outbreaks of increasing severity and mortality across Europe and North America.

Techlab continues to be at the forefront of C difficile research and with Inverness Medical are experts in the field of enteric diagnostics, offering a wide range of testing formats for the detection of C difficile antigen glutamate dehydrogenase and toxins A and B that can suit all laboratory practice and preference.

The product will not be available initially in the USA and Canada, where regulatory clearances are in process.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo